AstraZeneca's C$820 Million Investment in Canada: A Boon for Life Sciences and Economic Growth

AstraZeneca, a global pharmaceutical company, has announced a significant C$820 million (US$570 million) investment in Canada, creating more than 700 high-skilled jobs across all areas of the business. This investment will support the move to a larger, state-of-the-art office facility in the Greater Toronto Area (GTA), Ontario, and contribute to the company's global ambition to achieve US$80 billion in Total Revenue and to bring 20 new medicines to patients around the world by 2030.